Abstract
The aim was to determine whether increased CK8 and BCRP expression cooperatively contribute to multidrug resistance (MDR) in MCF-7/MX cells. Accumulating evidence suggests that the development and maintenance of cancer MDR involves complex multimodal mechanisms that interact concomitantly and complementarily. In this report, we observed elevated expression of cytokeratin 8 (CK8) in MCF-7/MX, a mitoxantrone (MX)-selected human breast tumor cell line with the MDR phenotype known as overexpression of breast cancer resistant protein (BCRP). Gene transfection methods were used to express CK8 and BCRP in NIH3T3 fibroblasts, individually or in combination. Taken together, our present study suggests that CK8 together with BCRP may play significant roles in conferring the multifactorial MDR phenotype of MCF-7/MX cells, but may act independently via potentially different mechanisms. Although expressing either CK8 or BCRP alone was able to confer resistance to mitoxantrone, cells co-expressing both proteins demonstrated significantly increased drug resistance. Furthermore, RNAi knockdown of CK8 and BCRP, alone and in combination, in MCF-7/MX cells significantly attenuated their resistance to chemotherapeutic agents. Interestingly, in cont...Continue Reading
References
Jun 7, 1994·Proceedings of the National Academy of Sciences of the United States of America·P A BaumanA E Cress
Dec 1, 1996·Cancer Metastasis Reviews·R G OshimaC Caulín
Dec 1, 1996·Cancer Metastasis Reviews·A E Cress, W S Dalton
Apr 1, 1997·Gene·H Lage, M Dietel
May 29, 1997·International Journal of Cancer. Journal International Du Cancer·U KellnerS H Kaufmann
Apr 1, 1997·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·E MoranM Clynes
Aug 13, 1998·Cytometry·I BrotherickM J Higgs
Mar 10, 1999·Journal of the National Cancer Institute·D D RossL A Doyle
Sep 22, 2001·Biochimica Et Biophysica Acta·K J Bailey-DellD D Ross
Jun 26, 2002·Cancer Gene Therapy·Petra KowalskiHermann Lage
Sep 5, 2002·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·Jesus M Paramio, José L Jorcano
Oct 9, 2002·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Yoko FukunagaToshihiko Ishida
Jul 15, 2004·International Journal of Cancer. Journal International Du Cancer·Ujwala RaulMilind Vaidya
Jan 11, 2005·The Journal of Pathology·D B Longley, P G Johnston
Jun 22, 2005·Life Sciences·Bian-Sheng JiGuo-Qing Liu
Oct 27, 2005·Journal of Cellular Physiology·Annalisa RobertiCaterina Cinti
Mar 7, 2006·Nature Reviews. Drug Discovery·Gergely SzakácsMichael M Gottesman
Mar 17, 2006·Biochemical and Biophysical Research Communications·Olivier GiresChristoph Matthias
Apr 14, 2006·Chemotherapy·L O'Driscoll, M Clynes
Sep 19, 2006·Oligonucleotides·Axel PriebschHermann Lage
Nov 30, 2006·Life Sciences·Ling LiXun Hu
May 8, 2007·Biochemical and Biophysical Research Communications·Sung-Tsai YuYen-Hui Chen
Citations
Sep 10, 2013·Cancer Chemotherapy and Pharmacology·Yunhui HuDongsheng Xiong
Apr 30, 2013·Cancer Letters·Shuangyuan ZhouJie Li
Oct 5, 2010·Oncogene·V Karantza
Feb 18, 2011·DNA and Cell Biology·Fatemeh MosaffaJavad Behravan
Nov 1, 2011·Human Molecular Genetics·Julien ColasAleksander Edelman
Apr 19, 2013·Experimental Hematology & Oncology·Patrizia CerutiFrancesco Novelli
May 21, 2010·Genome Biology·Rachel A HeimeierYun-Bo Shi
Aug 21, 2012·Endocrine-related Cancer·Xinying LiCui Li
Apr 30, 2014·Archives of Toxicology·Márton JaniPéter Krajcsi
Jan 18, 2012·Biochemical Pharmacology·Karthika NatarajanDouglas D Ross
Aug 4, 2015·Nature Communications·Juan D ChavezJames E Bruce
Oct 7, 2014·Biochimica Et Biophysica Acta·Matthew Trendowski
Aug 1, 2014·Biochimica Et Biophysica Acta·Mafalda VideiraMaria Alexandra Brito
Jul 25, 2013·Cancer Letters·Meng-Tao MaMin-Jie Wei
Oct 7, 2016·PloS One·Sandy LiuIsla P Garraway
Oct 27, 2015·Drugs·Matthew Trendowski
Nov 15, 2011·Journal of Clinical Pathology·Mark K Heatley